MB "Klaipėdos endobiogenika" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 1,494 |
| - |
| -3,093 |
| -3,093 |
| - |
| -169.34 |
| -207.03 |
| -2,693 |
| 2,693 |
| 0 |
| 0 |
| 2024 |
|---|
| 4,214 |
| - |
| -2,813 |
| -2,813 |
| - |
| -20.84 |
| -66.75 |
| -5,506 |
| 6,559 |
| 0 |
| 1,053 |
| 2025 |
|---|
| 5,300 |
| - |
| -2,964 |
| -2,964 |
| - |
| -4.91 |
| -55.92 |
| -8,470 |
| 8,666 |
| 0 |
| 196 |
Register and
explore Okredo data| 2025 |
|---|
| 5,300 |
| - |
| -2,964 |
| -2,964 |
| - |
| -4.91 |
| -55.92 |
| -8,470 |
| 8,666 |
| 0 |
| 196 |
Register and
explore Okredo dataTurnover (€)
2025
Turnover (€)
5,300 €26 % *
Sales per employee (€)
-Profit before tax (€)
-2,964 €-5 % *
Net Profit (€)
-2,964 €-5 % *
Profit per employee (€)
-Total profitability (%)
-4.91 %76.44 % *
Net profitability (%)
-55.92 %16.22 % *
Equity (€)
-8,470 €-54 % *
Amounts Payable And Liabilities (€)
8,666 €32 % *
Non-current Assets (€)
0 €- *
CurrentAssets (€)
196 €-81 % *
